GlassScriptPhysician profile
Scott M Linacre
NPI 1295974566
$18,766.42
in general payments reported to CMS, 2019-2025
23 companies · $7,310 in 2025
The $7,310 reported for 2025 was more than what 99% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,882 · 2022: $2,482 · 2023: $1,534 · 2024: $5,559 · 2025: $7,310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,763 · Consulting Fee: $2,430 · Travel and Lodging: $2,164 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,763.06 |
| Consulting Fee | $2,430.00 |
| Travel and Lodging | $2,164.17 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,276.91 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Accurian |
| Curonix LLC | $4,695.54 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $2,509.91 | 2021-2025 | Relistor |
| Nalu Medical, INC. | $844.29 | 2022-2023 | Nalu Neurostimulation System |
| Foundation Fusion Solutions, LLC | $704.14 | 2024-2025 | |
| Vertos Medical, INC. | $605.92 | 2024 | Mild Device Kit |
| Boston Scientific Corporation | $509.16 | 2021-2025 | Intracept |
| Spinal Simplicity, LLC | $425.23 | 2025 | Ha Minuteman G3-R |
| Stryker Corporation | $289.14 | 2024-2025 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $157.79 | 2021-2023 | Belbuca |
| Forte Bio-Pharma LLC | $149.76 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Horizon Therapeutics Plc | $127.39 | 2021-2022 | |
| Amgen INC. | $120.88 | 2021 | |
| Uswm, LLC | $88.89 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $83.36 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valinor Pharma, LLC | $37.72 | 2025 | Movantik |
| Azurity Pharmaceuticals, INC. | $32.54 | 2023 | Horizant |
| Bioventus LLC | $21.78 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $20.49 | 2025 | |
| Almatica Pharma LLC | $19.99 | 2021 | |
| Merz Pharmaceuticals, LLC | $15.67 | 2024 | Xeomin |
| Kowa Pharmaceuticals America, INC. | $15.34 | 2022 | |
| Grt US Holding, INC. | $14.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Linacre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.